skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices
Tipo de recurso Mostra resultados com: Mostra resultados com: Índice

Biomarkers and Precision Medicine in Alzheimer’s Disease

Sagar, Ram ; Pathak, Pujita ; Pandur, Balint ; Kim, Sujung Jun ; Li, Jiaxin ; Mahairaki, Vasiliki Vlamos, Panayiotis

Advances in experimental medicine and biology, 2021-01, Vol.1339, p.403-408 [Periódico revisado por pares]

Switzerland: Springer International Publishing AG

Sem texto completo

Citações Citado por
  • Título:
    Biomarkers and Precision Medicine in Alzheimer’s Disease
  • Autor: Sagar, Ram ; Pathak, Pujita ; Pandur, Balint ; Kim, Sujung Jun ; Li, Jiaxin ; Mahairaki, Vasiliki
  • Vlamos, Panayiotis
  • Assuntos: Aged ; Alzheimer Disease - diagnosis ; Alzheimer Disease - drug therapy ; Alzheimer Disease - genetics ; Alzheimer’s precision medicine ; Amyloid beta-Peptides ; Biomarkers ; Disease Progression ; Humans ; Precision Medicine ; tau Proteins - genetics
  • É parte de: Advances in experimental medicine and biology, 2021-01, Vol.1339, p.403-408
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: Alzheimer’s disease (AD) is the most common form of dementia in the elderly, which is the fifth major cause of mortality for people over 65 years. While some of the hereditary genetic risk factors can be connected to the known amyloid and tau hypothesis, many treatments targeting this pathophysiology have failed in clinical trials or ineffectiveness of the drugs are attributed to the heterogeneous and multifactorial nature of AD. Thus, there is an urgent need to focus on finding therapeutic targets that can mitigate disease progression on patient based personalized medicine. This approach of precision medicine can tailor the potential treatment to a specific individual, so it is optimized for the maximum efficacy with minimum risk of side effects. To be able to understand varying responses among patients, identifying biomarkers that can be used as the therapeutic effectiveness will be of great interest. Here we describe advancement of precision medicine and biomarkers that can be essential tools for detection of the disease as well as for a marker of disease progression after intervention.
  • Editor: Switzerland: Springer International Publishing AG
  • Idioma: Inglês
Links
Voltar para lista de resultados
Ir para página anteriorAnterior Resultado  3 AvançarIr para próxima página

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.